Galena Biopharma, a
biopharmaceutical company developing and commercializing innovative, targeted
oncology treatments that address major unmet medical needs to advance cancer
care, says it will be presenting at the 16th Annual BIO CEO & Investor
Conference next week in New York City. The company’s President and Chief
Executive Officer, Mark J. Anh, Ph.D. will deliver a corporate update at the
conference on Monday, February 10, 2014 at 9:00 am EST.
The conference is taking
place at the Waldorf Astoria Hotel in New York City, New York. Those who wish
to see the presentation are advised to visit the Investors section of Galena
Biopharma’s website: http://investors.galenabiopharma.com.
Recently, Galena Biopharma’s
share price rose from $5.00 on December 31, 2013 to over $7.00 in the past
three weeks. That, say analysts, stems from the positive news that has been
emerging concerning the biopharmaceutical company’s oncology treatments.
More information about
Galena Biopharma and its growth potential can be found at:
www.galenabiopharma.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
